Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

Search Cook Medical

Interventional Radiology
May 2nd, 2017

Preventing CLABSIs: the importance of training


Jared

According to the CDC’s Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011, an important part of preventing central line-associated bloodstream infections (CLABSIs) is to “educate healthcare personnel regarding the indications for intravascular catheter use, proper procedures for insertion and maintenance of intravascular catheters, and appropriate infection control measures to prevent intravascular catheter-related infections.”[1]

The Cook Medical Clinical Specialist team has a combined 114 years of clinical experience working with vascular access devices.


“The most important part of a training program is establishing the needs of the hospital’s team,” says Cook Clinical Specialist Linda Burns. “We like to meet with the facility and customize a program that meets its particular challenges.”


As Cook Clinical Specialist Diana Melton explains, the training is comprehensive, covering anatomy and physiology, the types of therapies that require a PICC or central venous catheter (CVC), various kinds of vascular access devices, how to select an appropriate insertion site, insertion techniques, and the use of ultrasound. Training also focuses on general care and maintenance of the catheter, possible complications, and treatment plans.

This type of training is important for helping to prevent CLABSIs, says Cook Clinical Specialist Jarred Olson, because it helps emphasize and reinforce sterile and safe techniques for catheter insertion and maintenance. “Using maximal sterile barrier precautions and tools such as Cook Spectrum® antimicrobial catheters helps lower the risk for catheter-related bloodstream infections (CRBSIs)[2],” he says, “but you also have to know how to properly insert and maintain the catheter, which is why ongoing training is so important.”

Maximal Sterile Barrier precations

For Cook Clinical Specialist Jon Jacobs, training provides clinicians with an opportunity to maintain and improve their skills. “A central part of the training we offer is a thorough evaluation of the trainees’ insertion and maintenance process, and we provide instruction for how to improve in every phase,” he says. “It’s often the little things that add up to make a big difference in lowering the risk for CLABSIs.”

nurses_horizontal

Cook Spectrum catheters meet the CDC’s 1A recommendation as a component of the prevention of CLABSIs.[3]

To learn more about Cook Medical’s Clinical Specialist team and to discuss your training needs, email us at spectrum@cookmedical.com.

Learn more about the science of Cook Spectrum® technology at spectrum.cookmedical.com.

Learn more about how bloodstream infections hurt patients and hospitals.

[1] O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections, 2011. Centers for Disease Control and Infection website. www.cdc.gov/hicpac/pdf/guidelines/bsi-guidelines-2011.pdf. Updated April 1, 2011. Accessed Jan. 6, 2017.
[2] Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med. 1997;127(4):267-274.
[3] O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections, 2011. Centers for Disease Control and Infection website. www.cdc.gov/hicpac/pdf/guidelines/bsi-guidelines-2011.pdf. Updated April 1, 2011. Accessed July 21, 2016. The 1A recommendation from the Centers for Disease Control and Prevention (CDC) is to “Use a chlorhexidine/silver sulfadiazine or minocycline/rifampin -impregnated CVC in patients whose catheter is expected to remain in place >5 days if, after successful implementation of a comprehensive strategy to reduce rates of CLABSI, the CLABSI rate is not decreasing.”

AB_T_UPICABRM_REV0